SteveHsukwoChinMD
Hematology • Charleston, SCAssistant Professor, Psychiatry and Behavioral Sciences, Medical University of South Carolina College of Medicine
Dr. Chin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
171 Ashley Ave
Msc 861
Charleston, SC 29425Phone+1 843-792-7267Fax+1 843-792-3187
Education & Training
Wayne State University School of MedicineResidency, Internal Medicine/Psychiatry, 2000 - 2005
Spartan Health Sciences UniversityClass of 1998
Certifications & Licensure
PA State Medical License 2005 - 2022
SC State Medical License 2009 - 2015
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
- A Feasibility and Safety Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells in Patients With Metastatic, Locally Advanced, Unresectable, or Recurrent Pancreatic Adenocarcinoma Start of enrollment: 2011 Aug 01
- Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer Patients Start of enrollment: 2011 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 35 citationsDisparity in hospice utilization by African American patients with cancer.Stephen J. Ramey, Steve H. Chin
The American Journal of Hospice & Palliative Care. 2012-08-01 - 31 citationsDepression and anxiety symptoms relate to distinct components of pain experience among patients with breast cancerSarah K. Galloway, Megan K. Baker, Pierre Giglio, Steve H. Chin, Alok Madan
Pain Research and Treatment. 2012-11-21 - 107 citationsVaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer.Shikhar Mehrotra, Carolyn D. Britten, Steve Chin, Elizabeth Garrett-Mayer, Colleen A. Cloud
Journal of Hematology & Oncology. 2017-04-07
Press Mentions
Elpiscience Announces First Patient Dosed for Phase 1 Clinical Trial of First-in-Class Anti-CD39xTGF-Β Bispecific Antibody ES014February 27th, 2023- Elpiscience Announces CDE IND Clearance of ES014, a First in Class Anti-CD39xTGF-Β Bispecific Antibody for Patients with Advanced Solid TumorsDecember 22nd, 2022
- CTX-009 (ABL001/ES104) Clinical Data Presented Today at the New Drugs on the Horizon Plenary Session of the 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsOctober 8th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
